New GutGuide® EPO patent indicates that lactic acid bacteria are balancing intestinal microbiota of coeliacs

EPO patent 3164143 “Microbiomarker for celiac disease and a related product” granted to GutGuide® Oy on 02.04.2020 is based on the correlation between the balance of the intestinal microbiota of celiac disease and the combination of Lactobacillus SPI and Bifidobacterium lactis BLC. GutIndex analysis and a bacterial product are also connected to the innovation.

GutGuide®ProVillus bacteria product contains both bacterial strains related to the patented invention.

Read more about ProVillus >

Comments are closed.